Results

Total Results: 1,430 records

Showing results for "continued".

61. Alcohol-Misuse-Drug-Therapy Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
    January 27, 2012 - (4) Continued alcohol use despite having persistent or recurrent social or interpersonal problems … (b) Markedly diminished effect with continued use of the same amount of alcohol. … problem that is likely to have been caused or exacerbated by alcohol (e.g., continued drinking despite … Continued alcohol use despite having persistent or recurrent social or interpersonal problems caused … (2) A markedly diminished effect with continued use of the same amount of alcohol. K.

62. Blood-Clots-Hip-Knee-Surgery Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_executive.pdf
    March 01, 2012 - Summary of results from base case analyses in patients who had major orthopedic surgery*6 (continued … Summary of results from base case analyses in patients who had major orthopedic surgery*6 (continued … DVT (continued) LMWH vs. … Summary of results from base case analyses in patients who had major orthopedic surgery*6 (continued … Symptomatic DVT (continued) LMWH vs.

63. Comparative Effectiveness Reiew 243_Prehospital Airway Management: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-evidence-summary_0.pdf
    June 01, 2021 - Continued on page 2 2  When SGA was compared with ETI, outcomes measured by the … Continued on page 3 3 Background and Purpose Emergency medical services care for people

64. Choice-Of-Mean White-Paper (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/choice-of-mean_white-paper.pdf
    April 01, 2015 - change score and endpoints (comparison between different treatments) based on PL and DL methods, (continued … change score and endpoints (comparison between different treatments) based on PL and DL methods, (continued … Comparison of Combined Mean Differences Using Change Score and Endpoints (Treatment Versus Control) (continued … Comparison of Combined Mean Differences Using Change Score and Endpoints (Treatment Versus Control) (continued … Combined Mean Differences Using Change Score and Endpoints (Comparison Between Different Treatments) (continued

65. Measuring-Blood-Pressure Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
    January 01, 2012 - Summary of findings of studies addressing Key Questions on self-measured blood pressure monitoring (continued … Summary of findings of studies addressing Key Questions on self-measured blood pressure monitoring (continued … Summary of findings of studies addressing Key Questions on self-measured blood pressure monitoring (continued … Summary of findings of studies addressing Key Questions on self-measured blood pressure monitoring (continued … Summary of findings of studies addressing Key Questions on self-measured blood pressure monitoring (continued

66. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
    August 12, 2016 - Rice, PhD/ Global Organization for EPA and DHA Omega‐3s (GOED) BP, continued The confusion is due … Rice, PhD/ Global Organization for EPA and DHA Omega‐3s (GOED) BP, continued In that meta-analysis … Continued in next row. … continued) Continued from previous row. … Rice, PhD/ Global Organization for EPA and DHA Omega‐3s (GOED) BP, continued As an aside, there

67. Hepatitis-C Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
    November 01, 2012 - Summary of evidence on comparative effectiveness of treatment for hepatitis C (continued) Key Question … Summary of evidence on comparative effectiveness of treatment for hepatitis C (continued) Key Question … (continued) Triple Therapy With Pegylated Interferon Alfa-2a or Alfa-2b, Ribavirin, and Telaprevir … (continued) Triple Therapy With Pegylated Interferon Alfa-2a or Alfa-2b, Ribavirin, and Telaprevir … (continued) Triple Therapy With Pegylated Interferon Alfa-2a or Alfa-2b, Ribavirin, and Telaprevir

68. Osteoporosis-Bone-Fracture Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
    March 01, 2012 - Two issues of particular interest were the continued use of placebo (as opposed to active) controls … How does the antifracture benefit vary with long-term continued use of therapy? … Summary of evidence (continued) Strength of Evidence Conclusion f. … Summary of evidence (continued) Strength of Evidence Conclusion Moderate Reduction in fracture risk … How does the antifracture benefit vary with long-term continued use of pharmacotherapy?

69. Antipsychotics-Adults Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
    August 01, 2012 - Summary of the strength of evidence for core illness symptoms (KQ1) (continued) Outcome Comparison SoE … Outcome Comparison Summary (Number of Studies) Schizophrenia and Schizophrenia-Related Psychoses (continued … ) Health care system use (continued) Perphenazine vs. quetiapine No significant difference in rates … Summary of the evidence for other outcomes (KQ4) (continued) Comparison Summarya (Number of Studies) … Schizophrenia and Schizophrenia-Related Psychoses (continued) Perphenazine vs. olanzapine No significant

70. Engaging Stakeholders to Identify and Prioritize Topics for Future Research: Recommended activities and reporting practices (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_research-2011.pdf
    January 01, 2011 - Identify and Prioritize Topics for Future Research: Recommended activities and reporting practices (continued

71. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
    January 01, 2007 - PHS 398 (Rev. 9/04), Continuation Page Award: CERTs Comparative Effectiveness Supplement (U18HS010399-06S1) Project Title: Validation of Outcomes in Centers for Medicare & Medicaid Services (CMS) Data Principal Investigator: Brian L. Strom, MD, MPH Co-Principal Investigator: Sean Hennessy, PharmD…

72. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
    January 01, 2005 - PHS 398 (Rev. 9/04), Continuation Page Award: CERTs Comparative Effectiveness Supplement (U18HS010399-06S1) Project Title: Validation of Outcomes in Centers for Medicare & Medicaid Services (CMS) Data Principal Investigator: Brian L. Strom, MD, MPH Co-Principal Investigator: Sean Hennessy, PharmD…

73. Slide 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_bonoff.pdf
    January 01, 2000 - Support for Patients and Consumers Engaged in Research Training & Support • Training and continued

74. Horizon Scanning Protocol and Operations Manual January 2013 Revision (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
    August 01, 2013 - and peer reviewed publications reviewed by ECRI medical librarians and/or horizon scanning analysts (continued … and peer reviewed publications reviewed by ECRI medical librarians and/or horizon scanning analysts (continued … and peer reviewed publications reviewed by ECRI medical librarians and/or horizon scanning analysts (continued … and peer reviewed publications reviewed by ECRI medical librarians and/or horizon scanning analysts (continued … and peer reviewed publications reviewed by ECRI medical librarians and/or horizon scanning analysts (continued

75. Data-Points-6-Maps (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-maps.pdf
    May 29, 2025 - Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service Population, by Hospital Referral Region, 2006 * Small cell = less than 11. Annual Utilization of Biologic Response Modifiers Among Continually Enrolled Medicare Parts A and B Fee-for-Service Popul…

76. Alcohol-misuse-drug-therapy-140326 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
    January 27, 2012 - recurrent alcohol-related legal problems (e.g., arrests for alcohol-related disorderly conduct); or (4) continued … amounts of alcohol to achieve intoxication or desired effect or (b) markedly diminished effect with continued … Definitions of the spectrum of alcohol misuse (continued) Term Definition Alcohol dependence11 (6) … ) (7) alcohol use is continued despite knowledge of having a persistent or recurrent physical or psychological … problem that is likely to have been caused or exacerbated by alcohol (e.g., continued drinking despite

77. Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
    December 20, 2017 - Published Online: December 20, 2017 19 Commentator & Affiliation Section Comment Response TEP #2 (continued … December 20, 2017 21 Commentator & Affiliation Section Comment Response Peer Reviewer #3 (continued … (continued) FeNO measurement has been directly evaluated in comparison with other diagnostic procedures … (continued) LaForce 2014: already included Hanania 2011: study evaluates the effectiveness of … (continued) Pavord 2012: the aim of this trial is to evaluate the effectiveness of Mepolizumab

78. Arthritis-Psoriatric Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
    April 01, 2012 - Summary of findings (continued) Key Comparisons Efficacy and Effectiveness Strength of Evidence Grade … Harms Strength of Evidence Grade Biologic DMARDs (continued) Biologic No head-to-head trials met … Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years

79. Training and Support for Patients and Consumers Engaged in Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/bonoff-text.pdf
    January 01, 2000 - Support for Patients and Consumers Engaged in Research Slide 2 Training & Support § Training and continued

80. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
    February 01, 2012 - Summary of the strength of evidence for symptoms (Key Question 1) (continued) Outcome Comparison (# … SGA (continued) Sedation Clozapine vs. olanzapine Low No significant difference. (1 RCT, 1 PCS, 1 RCS … Summary of the strength of evidence for adverse events (Key Question 2) (continued) Outcome Comparison … (# studies) SOE Summary SGA vs. placebo (continued) Prolactin-related Aripiprazole vs. placebo (3